Sanofi Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Sanofi stocks.

Sanofi Stocks Recent News

Date Stock Title
Apr 26 SNY Bristol, Sanofi, Takeda gain positive CHMP recommendations
Apr 26 SNY Pharma Stock Roundup: MRK, SNY, AZN, NVS' Q1 Results, Pipeline & Regulatory Updates
Apr 26 EXEL Analysts Estimate Immunome, Inc. (IMNM) to Report a Decline in Earnings: What to Look Out for
Apr 26 EXEL Merus (MRUS) Moves 7.1% Higher: Will This Strength Last?
Apr 26 MRK Investor Sentiment Improves Slightly, But Dow Tumbles Over 350 Points
Apr 25 ASND Ascendis Pharma to Report First Quarter 2024 Financial Results and Provide Business Update on May 2, 2024
Apr 25 MRK Merck (MRK) Q1 2024 Earnings Call Transcript
Apr 25 MRK Merck Stock Gains On Its Blockbuster Cancer Drug Keytruda, Raises Annual Outlook
Apr 25 MRK Merck & Co., Inc. (MRK) Q1 2024 Earnings Call Transcript
Apr 25 REGN AbbVie's Dermatitis Drug Shown 'Superior' To Sanofi/Regeneron's Dupixent In Head-To-Head Study
Apr 25 SNY AbbVie's Dermatitis Drug Shown 'Superior' To Sanofi/Regeneron's Dupixent In Head-To-Head Study
Apr 25 SNY Sanofi 2024 Q1 - Results - Earnings Call Presentation
Apr 25 MRK Merck (MRK) Q1 Earnings Top, Cancer Drug Keytruda Boosts Sales
Apr 25 MRK Heard on the Street: Bristol-Myers Goes From Big Pharma to Little Pharma
Apr 25 REGN Heard on the Street: Bristol-Myers Goes From Big Pharma to Little Pharma
Apr 25 MRK 20 Fastest Growing Health Tech Companies in the World
Apr 25 SNY 20 Fastest Growing Health Tech Companies in the World
Apr 25 SNY Sanofi (SNY) Q1 2024 Earnings Call Transcript
Apr 25 MRK Merck raises 2024 guidance on cancer drug demand
Apr 25 SNY Sanofi (SNY) Q1 Earnings In Line, Sales Miss Estimates, Stock Up
Sanofi

Sanofi S.A. is a French multinational pharmaceutical company headquartered in Paris, France, as of 2013 the world's fifth-largest by prescription sales. The company was formed as Sanofi-Aventis in 2004 by the merger of Aventis and Sanofi-Synthélabo, which were each the product of several previous mergers. It changed its name to Sanofi in May 2011. The company is a component of the Euro Stoxx 50 stock market index.Sanofi engages in the research and development, manufacturing and marketing of pharmaceutical drugs principally in the prescription market, but the firm also develops over-the-counter medication. The company covers seven major therapeutic areas: cardiovascular, central nervous system, diabetes, internal medicine, oncology, thrombosis and vaccines (it is the world's largest producer of the latter through its subsidiary Sanofi Pasteur).

Browse All Tags